Seagen Inc.

2023 Q4 Form 10-Q Financial Statement

#000106073623000047 Filed on November 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.237B
YoY Change -29.86%
Cash & Equivalents $428.6M
Short-Term Investments $808.4M
Other Short-Term Assets $151.9M
YoY Change 5.35%
Inventory $531.2M
Prepaid Expenses
Receivables $631.6M
Other Receivables $0.00
Total Short-Term Assets $2.552B
YoY Change -7.54%
LONG-TERM ASSETS
Property, Plant & Equipment $358.8M
YoY Change 55.8%
Goodwill $274.7M
YoY Change 0.0%
Intangibles $220.3M
YoY Change -9.48%
Long-Term Investments
YoY Change
Other Assets $100.1M
YoY Change 61.82%
Total Long-Term Assets $1.083B
YoY Change 25.97%
TOTAL ASSETS
Total Short-Term Assets $2.552B
Total Long-Term Assets $1.083B
Total Assets $3.634B
YoY Change 0.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $224.8M
YoY Change 55.58%
Accrued Expenses $729.9M
YoY Change 25.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $954.7M
YoY Change 31.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $15.64M
YoY Change -36.35%
Total Long-Term Liabilities $129.1M
YoY Change 81.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $954.7M
Total Long-Term Liabilities $129.1M
Total Liabilities $1.084B
YoY Change 35.94%
SHAREHOLDERS EQUITY
Retained Earnings -$2.756B
YoY Change 37.4%
Common Stock $5.302B
YoY Change 9.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.550B
YoY Change
Total Liabilities & Shareholders Equity $3.634B
YoY Change 0.42%

Cashflow Statement

Concept 2023 Q4 2023 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001060736
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-32405
dei Entity Registrant Name
EntityRegistrantName
SEAGEN INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-1874389
dei Entity Address Address Line1
EntityAddressAddressLine1
21823 30th Drive SE
dei Entity Address City Or Town
EntityAddressCityOrTown
Bothell
dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98021
dei City Area Code
CityAreaCode
425
dei Local Phone Number
LocalPhoneNumber
527-4000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001
dei Trading Symbol
TradingSymbol
SGEN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
188662672 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
428568000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
319940000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
808418000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
1415130000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
631555000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
501912000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
531188000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
427211000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
151864000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
138340000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
2551593000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
2802533000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
358801000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
248179000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
128861000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
46738000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
220255000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
237516000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
274671000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8835000 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
129124000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
52309000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
186559000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
186559000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
189000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
187000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5302239000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4954469000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4394000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3510000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2756401000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2154347000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
2550421000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2803819000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3634261000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3674532000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
648650000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
510300000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1772201000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1434262000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
165254000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
108122000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
457783000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
301848000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
449047000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
384605000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1204930000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
986518000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
265687000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
746060000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
604862000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
879988000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
703105000 usd
us-gaap Costs And Expenses
CostsAndExpenses
2408773000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-458966000 usd
CY2023Q3 sgen Equity Securities Fv Ni Gain Loss And Investment Income Net
EquitySecuritiesFvNiGainLossAndInvestmentIncomeNet
14978000 usd
CY2022Q3 sgen Equity Securities Fv Ni Gain Loss And Investment Income Net
EquitySecuritiesFvNiGainLossAndInvestmentIncomeNet
4278000 usd
sgen Equity Securities Fv Ni Gain Loss And Investment Income Net
EquitySecuritiesFvNiGainLossAndInvestmentIncomeNet
41463000 usd
sgen Equity Securities Fv Ni Gain Loss And Investment Income Net
EquitySecuritiesFvNiGainLossAndInvestmentIncomeNet
479000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-216360000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-188527000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-595109000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-458487000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-571000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2289000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6945000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3650000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-215789000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-190816000 usd
us-gaap Net Income Loss
NetIncomeLoss
-602054000 usd
us-gaap Net Income Loss
NetIncomeLoss
-462137000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.51
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
188135000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
188135000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
184792000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
184792000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
187532000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
187532000 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-215789000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-190816000 usd
us-gaap Net Income Loss
NetIncomeLoss
-602054000 usd
us-gaap Net Income Loss
NetIncomeLoss
-462137000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
97000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-875000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1639000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4472000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
189000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3363000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-755000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6288000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2488000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
884000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1816000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-215503000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-601170000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-460321000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3065139000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-136494000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-755000 usd
CY2022Q1 sgen Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan
26664000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
43913000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2998467000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-134827000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
83000 usd
CY2022Q2 sgen Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan
14960000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
54129000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2932812000 usd
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q4 us-gaap Goodwill
Goodwill
274671000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
100080000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
64895000 usd
CY2023Q3 us-gaap Assets
Assets
3634261000 usd
CY2022Q4 us-gaap Assets
Assets
3674532000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
224813000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
207851000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
729903000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
610553000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
954716000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
818404000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
113487000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
43474000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15637000 usd
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
188628000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
188628000 shares
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
210378000 usd
us-gaap Costs And Expenses
CostsAndExpenses
1893228000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-231338000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-192805000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-636572000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.15
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.15
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.03
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.21
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
184199000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
184199000 shares
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
286000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-188328000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-190816000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2488000 usd
CY2022Q3 sgen Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan
18388000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
58938000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2821811000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2803819000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-174737000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
198000 usd
CY2023Q1 sgen Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan
42240000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
12303000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
63939000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2723156000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-211528000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
400000 usd
CY2023Q2 sgen Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan
13815000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
93216000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2619059000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-215789000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
286000 usd
CY2023Q3 sgen Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan
15520000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
2000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
131343000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
2550421000 usd
us-gaap Net Income Loss
NetIncomeLoss
-602054000 usd
us-gaap Net Income Loss
NetIncomeLoss
-462137000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
288498000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
156980000 usd
us-gaap Depreciation
Depreciation
38056000 usd
us-gaap Depreciation
Depreciation
34642000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17261000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17261000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
11339000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
9441000 usd
sgen Debt Securities Realized Gain Loss And Accretion Amortization Of Discounts And Premiums
DebtSecuritiesRealizedGainLossAndAccretionAmortizationOfDiscountsAndPremiums
34333000 usd
sgen Debt Securities Realized Gain Loss And Accretion Amortization Of Discounts And Premiums
DebtSecuritiesRealizedGainLossAndAccretionAmortizationOfDiscountsAndPremiums
1129000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-2750000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-9747000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
835000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-221000 usd
us-gaap Inventory Write Down
InventoryWriteDown
46524000 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
129643000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
97499000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
150501000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
164307000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
53186000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11300000 usd
sgen Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
10257000 usd
sgen Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
11842000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
114000000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
146053000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-460711000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-374311000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1699316000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2060242000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
2342000000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
2391000000 usd
sgen Payments To Acquire Lessor Owned Assets
PaymentsToAcquireLessorOwnedAssets
2954000 usd
sgen Payments To Acquire Lessor Owned Assets
PaymentsToAcquireLessorOwnedAssets
17936000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
131815000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
48095000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
507915000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
264727000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
71577000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
60013000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12303000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59274000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
60013000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-804000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-6893000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
105674000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-56464000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
323486000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
424834000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
429160000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
368370000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
53300000 usd
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
20100000 usd
CY2023Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
0 usd
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
5200000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
600000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
288498000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
156980000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
545300000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-600000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6900000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
428568000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
319940000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
592000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3546000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
429160000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
323486000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
305650000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
305650000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
85395000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
68134000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
220255000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
237516000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5817000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5817000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17261000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17261000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5800000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
23100000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
23100000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
23100000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
23100000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
23100000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
648650000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
510300000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1772201000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1434262000 usd
CY2021Q2 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
258000 sqft
CY2021Q2 sgen Rentable Building And Complex Constructed
RentableBuildingAndComplexConstructed
20.5 acre
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
4000000 usd
CY2021Q2 sgen Operating Lease Annual Escalations Percentage
OperatingLeaseAnnualEscalationsPercentage
0.03
CY2021Q2 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P20Y
CY2021Q2 sgen Lessee Operating Lease Option To Extend Number
LesseeOperatingLeaseOptionToExtendNumber
2 term
CY2021Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P10Y
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.003
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
5514000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3682000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
16426000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
11824000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
1307000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
1039000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
3870000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
3360000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
6821000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
4721000 usd
us-gaap Lease Cost
LeaseCost
20296000 usd
us-gaap Lease Cost
LeaseCost
15184000 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
5307000 usd
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
4089000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
14215000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
12838000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y2M12D
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y4M24D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.069
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.050
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11089000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14517000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
113487000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
43474000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
124576000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
57991000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.012
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2300000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3600000 usd
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9000000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9948000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8699000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10029000 shares
us-gaap Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded
DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded
0 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded
DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded
0 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded
DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded
0 usd
us-gaap Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded
DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded
0 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.012
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.008
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
491000 usd
CY2022Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2669000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2750000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-9747000 usd
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
14487000 usd
CY2022Q3 us-gaap Investment Income Net
InvestmentIncomeNet
6947000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
44213000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
10226000 usd
CY2023Q3 sgen Equity Securities Fv Ni Gain Loss And Investment Income Net
EquitySecuritiesFvNiGainLossAndInvestmentIncomeNet
14978000 usd
CY2022Q3 sgen Equity Securities Fv Ni Gain Loss And Investment Income Net
EquitySecuritiesFvNiGainLossAndInvestmentIncomeNet
4278000 usd
sgen Equity Securities Fv Ni Gain Loss And Investment Income Net
EquitySecuritiesFvNiGainLossAndInvestmentIncomeNet
41463000 usd
sgen Equity Securities Fv Ni Gain Loss And Investment Income Net
EquitySecuritiesFvNiGainLossAndInvestmentIncomeNet
479000 usd
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12845000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
14916000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
479584000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
357275000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
38759000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
55020000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
531188000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
427211000 usd
us-gaap Inventory Write Down
InventoryWriteDown
47000000 usd
CY2023Q3 sgen Clinical Trial And Related Costs Current
ClinicalTrialAndRelatedCostsCurrent
222488000 usd
CY2022Q4 sgen Clinical Trial And Related Costs Current
ClinicalTrialAndRelatedCostsCurrent
194006000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
212442000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
175506000 usd
CY2023Q3 sgen Accrued Gross To Net Deductions And Third Party Royalties Current
AccruedGrossToNetDeductionsAndThirdPartyRoyaltiesCurrent
153266000 usd
CY2022Q4 sgen Accrued Gross To Net Deductions And Third Party Royalties Current
AccruedGrossToNetDeductionsAndThirdPartyRoyaltiesCurrent
119289000 usd
CY2023Q3 sgen Business Combination Accrued Acquisition Related Costs
BusinessCombinationAccruedAcquisitionRelatedCosts
27445000 usd
CY2022Q4 sgen Business Combination Accrued Acquisition Related Costs
BusinessCombinationAccruedAcquisitionRelatedCosts
0 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
114262000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
121752000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
729903000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
610553000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
131343000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
58938000 usd
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001060736-23-000047-index-headers.html Edgar Link pending
0001060736-23-000047-index.html Edgar Link pending
0001060736-23-000047.txt Edgar Link pending
0001060736-23-000047-xbrl.zip Edgar Link pending
ex-3112023q3.htm Edgar Link pending
ex-3122023q3.htm Edgar Link pending
ex-3212023q3.htm Edgar Link pending
ex-3222023q3.htm Edgar Link pending
ex101forfilingxformofglo.htm Edgar Link pending
ex101forfilingxformofglo001.jpg Edgar Link pending
ex101forfilingxformofglo002.jpg Edgar Link pending
ex101forfilingxformofglo003.jpg Edgar Link pending
ex101forfilingxformofglo004.jpg Edgar Link pending
ex101forfilingxformofglo005.jpg Edgar Link pending
ex101forfilingxformofglo006.jpg Edgar Link pending
ex101forfilingxformofglo007.jpg Edgar Link pending
ex101forfilingxformofglo008.jpg Edgar Link pending
ex101forfilingxformofglo009.jpg Edgar Link pending
ex101forfilingxformofglo010.jpg Edgar Link pending
ex101forfilingxformofglo011.jpg Edgar Link pending
ex101forfilingxformofglo012.jpg Edgar Link pending
ex101forfilingxformofglo013.jpg Edgar Link pending
ex101forfilingxformofglo014.jpg Edgar Link pending
ex101forfilingxformofglo015.jpg Edgar Link pending
ex101forfilingxformofglo016.jpg Edgar Link pending
ex101forfilingxformofglo017.jpg Edgar Link pending
ex101forfilingxformofglo018.jpg Edgar Link pending
ex101forfilingxformofglo019.jpg Edgar Link pending
ex101forfilingxformofglo020.jpg Edgar Link pending
ex101forfilingxformofglo021.jpg Edgar Link pending
ex101forfilingxformofglo022.jpg Edgar Link pending
ex101forfilingxformofglo023.jpg Edgar Link pending
ex101forfilingxformofglo024.jpg Edgar Link pending
ex101forfilingxformofglo025.jpg Edgar Link pending
ex101forfilingxformofglo026.jpg Edgar Link pending
ex101forfilingxformofglo027.jpg Edgar Link pending
ex101forfilingxformofglo028.jpg Edgar Link pending
ex101forfilingxformofglo029.jpg Edgar Link pending
ex101forfilingxformofglo030.jpg Edgar Link pending
ex101forfilingxformofglo031.jpg Edgar Link pending
ex101forfilingxformofglo032.jpg Edgar Link pending
ex101forfilingxformofglo033.jpg Edgar Link pending
ex101forfilingxformofglo034.jpg Edgar Link pending
ex101forfilingxformofglo035.jpg Edgar Link pending
ex101forfilingxformofglo036.jpg Edgar Link pending
ex101forfilingxformofglo037.jpg Edgar Link pending
ex101forfilingxformofglo038.jpg Edgar Link pending
ex101forfilingxformofglo039.jpg Edgar Link pending
ex101forfilingxformofglo040.jpg Edgar Link pending
ex102forfilingxformofglo.htm Edgar Link pending
ex102forfilingxformofglo001.jpg Edgar Link pending
ex102forfilingxformofglo002.jpg Edgar Link pending
ex102forfilingxformofglo003.jpg Edgar Link pending
ex102forfilingxformofglo004.jpg Edgar Link pending
ex102forfilingxformofglo005.jpg Edgar Link pending
ex102forfilingxformofglo006.jpg Edgar Link pending
ex102forfilingxformofglo007.jpg Edgar Link pending
ex102forfilingxformofglo008.jpg Edgar Link pending
ex102forfilingxformofglo009.jpg Edgar Link pending
ex102forfilingxformofglo010.jpg Edgar Link pending
ex102forfilingxformofglo011.jpg Edgar Link pending
ex102forfilingxformofglo012.jpg Edgar Link pending
ex102forfilingxformofglo013.jpg Edgar Link pending
ex102forfilingxformofglo014.jpg Edgar Link pending
ex102forfilingxformofglo015.jpg Edgar Link pending
ex102forfilingxformofglo016.jpg Edgar Link pending
ex102forfilingxformofglo017.jpg Edgar Link pending
ex102forfilingxformofglo018.jpg Edgar Link pending
ex102forfilingxformofglo019.jpg Edgar Link pending
ex102forfilingxformofglo020.jpg Edgar Link pending
ex102forfilingxformofglo021.jpg Edgar Link pending
ex102forfilingxformofglo022.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sgen-20230930.htm Edgar Link pending
sgen-20230930.xsd Edgar Link pending
sgen-20230930_g1.jpg Edgar Link pending
sgen-20230930_g2.jpg Edgar Link pending
sgen-20230930_g3.jpg Edgar Link pending
sgen-20230930_g4.jpg Edgar Link pending
Show.js Edgar Link pending
sgen-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
sgen-20230930_def.xml Edgar Link unprocessable
sgen-20230930_lab.xml Edgar Link unprocessable
sgen-20230930_pre.xml Edgar Link unprocessable
sgen-20230930_htm.xml Edgar Link completed